53BP1 mediates sensitivity to chemotherapy and is associated with poor clinical outcomes in high-grade serous ovarian cancer
Preprint in bioRxiv (October 2023)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
Preprint in bioRxiv (October 2023)
Article in International Journal of Molecular Sciences (September 2023)
Article in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (June 2023)